These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32966755)

  • 1. Aprepitant for Cough in Lung Cancer. A Randomized Placebo-controlled Trial and Mechanistic Insights.
    Smith JA; Harle A; Dockry R; Holt K; Russell P; Molassiotis A; Yorke J; Robinson R; Birrell MA; Belvisi MG; Blackhall F
    Am J Respir Crit Care Med; 2021 Mar; 203(6):737-745. PubMed ID: 32966755
    [No Abstract]   [Full Text] [Related]  

  • 2. Aprepitant for Cough Suppression in Advanced Lung Cancer: A Randomized Trial.
    Noronha V; Bhattacharjee A; Patil VM; Joshi A; Menon N; Shah S; Kannan S; Mukadam SA; Maske K; Ishi S; Prabhash K
    Chest; 2020 Jun; 157(6):1647-1655. PubMed ID: 31958446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging targets for cough therapies; NK1 receptor antagonists.
    Badri H; Smith JA
    Pulm Pharmacol Ther; 2019 Dec; 59():101853. PubMed ID: 31622673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough.
    Belvisi MG; Birrell MA; Wortley MA; Maher SA; Satia I; Badri H; Holt K; Round P; McGarvey L; Ford J; Smith JA
    Am J Respir Crit Care Med; 2017 Nov; 196(10):1255-1263. PubMed ID: 28650204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurokinin-1 Receptor Inhibition and Cough.
    Turner RD; Birring SS
    Am J Respir Crit Care Med; 2021 Mar; 203(6):672-674. PubMed ID: 33108214
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer.
    Wu F; Lin X; Yang Z; Sun Z; Zeng F; Heng J; Qu J; Zeng L; Yang N; Zhang Y
    Clin Lung Cancer; 2018 Nov; 19(6):e913-e918. PubMed ID: 30197265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
    Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin.
    Yahata H; Kobayashi H; Sonoda K; Shimokawa M; Ohgami T; Saito T; Ogawa S; Sakai K; Ichinoe A; Ueoka Y; Hasuo Y; Nishida M; Masuda S; Kato K
    Int J Clin Oncol; 2016 Jun; 21(3):491-7. PubMed ID: 26662632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why Use Aprepitant Only as a Cough Suppressant in Lung Cancer When at Higher Doses it Could Also Exert an Antitumor Action?
    Muñoz M; Muñoz ME; Morell F; Coveñas R
    Arch Bronconeumol; 2022 Oct; 58(10):727-728. PubMed ID: 35606264
    [No Abstract]   [Full Text] [Related]  

  • 10. N-of-1 double-blind, randomized controlled trial of tramadol to treat chronic cough.
    Louly PG; Medeiros-Souza P; Santos-Neto L
    Clin Ther; 2009 May; 31(5):1007-13. PubMed ID: 19539101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial.
    Khalid S; Murdoch R; Newlands A; Smart K; Kelsall A; Holt K; Dockry R; Woodcock A; Smith JA
    J Allergy Clin Immunol; 2014 Jul; 134(1):56-62. PubMed ID: 24666696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline inhibits the cough reflex through a novel mechanism of action.
    Dubuis E; Wortley MA; Grace MS; Maher SA; Adcock JJ; Birrell MA; Belvisi MG
    J Allergy Clin Immunol; 2014 Jun; 133(6):1588-98. PubMed ID: 24406072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitussive effect of carcainium chloride in patients with chronic cough and idiopathic interstitial pneumonias: A pilot study.
    Lavorini F; Spina D; Walker MJ; Franciosi L; Page CP; Fontana GA
    Pulm Pharmacol Ther; 2016 Oct; 40():91-4. PubMed ID: 27538683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis.
    Piechotta V; Adams A; Haque M; Scheckel B; Kreuzberger N; Monsef I; Jordan K; Kuhr K; Skoetz N
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012775. PubMed ID: 34784425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the antitussive efficacy of codeine in cough associated with common cold.
    Freestone C; Eccles R
    J Pharm Pharmacol; 1997 Oct; 49(10):1045-9. PubMed ID: 9364418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancer.
    Kusagaya H; Inui N; Karayama M; Fujisawa T; Enomoto N; Kuroishi S; Nakamura Y; Matsuda H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Yamada T; Shirai T; Hayakawa H; Suda T
    Lung Cancer; 2015 Dec; 90(3):410-6. PubMed ID: 26791800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.
    Abdulqawi R; Dockry R; Holt K; Layton G; McCarthy BG; Ford AP; Smith JA
    Lancet; 2015 Mar; 385(9974):1198-205. PubMed ID: 25467586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled sodium cromoglycate to treat cough in advanced lung cancer patients.
    Moroni M; Porta C; Gualtieri G; Nastasi G; Tinelli C
    Br J Cancer; 1996 Jul; 74(2):309-11. PubMed ID: 8688342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Antitussive Therapy for Chronic Refractory Cough: Results From a Phase 2 Pilot Study (VOLCANO-1).
    Smith J; Allman D; Badri H; Miller R; Morris J; Satia I; Wood A; K Trower M
    Chest; 2020 Jan; 157(1):111-118. PubMed ID: 31421110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cough in Patients With Lung Cancer: A Longitudinal Observational Study of Characterization and Clinical Associations.
    Harle ASM; Blackhall FH; Molassiotis A; Yorke J; Dockry R; Holt KJ; Yuill D; Baker K; Smith JA
    Chest; 2019 Jan; 155(1):103-113. PubMed ID: 30321508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.